Manufacturers that audit their products for reclassification opportunities under the U.S. Harmonized Tariff Schedule are reaping significant cost savings, said Venky Ramesh of AlixPartners.

administrator
Related Articles
Patritumab Deruxtecan Meets Primary End Point in ICARUS-BREAST01…
- September 9, 2025